BRUKER CORPORATION Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax
BRUKER CORPORATION (BRKR) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax of -$7.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax · last filed 2026-02-27
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2025-12-31 was -$12.20M, a 147.66% decline year-over-year.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2025-09-30 was -$100.00K, a 111.11% decline year-over-year.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2025-06-30 was $4.40M, a 4300.00% increase year-over-year.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for the quarter ending 2025-03-31 was $800.00K.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2025 was -$7.10M, a 127.41% decline from fiscal 2024.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2024 was $25.90M, a 10.69% decline from fiscal 2023.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2023 was $29.00M.
- BRUKER CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2022 was -$56.80M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$12.30M derived: sum of 2 quarters · filed 2026-02-27 | -$7.90M derived: sum of 3 quarters · filed 2026-02-27 | -$7.10M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$100.00K 10-Q · filed 2025-11-05 | $4.30M derived: sum of 2 quarters · filed 2025-11-05 | $5.10M 10-Q · filed 2025-11-05 | $30.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | $4.40M 10-Q · filed 2025-08-06 | $5.20M 10-Q · filed 2025-08-06 | $30.80M derived: sum of 3 quarters · filed 2026-02-27 | $31.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $800.00K 10-Q · filed 2025-05-07 | $26.40M derived: sum of 2 quarters · filed 2026-02-27 | $27.30M derived: sum of 3 quarters · filed 2026-02-27 | $27.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | $25.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $26.50M derived: sum of 2 quarters · filed 2026-02-27 | $26.60M derived: sum of 3 quarters · filed 2026-02-27 | $25.90M 10-K · filed 2026-02-27 |
| 2024-09-30 | $900.00K 10-Q · filed 2025-11-05 | $1.00M derived: sum of 2 quarters · filed 2025-11-05 | $300.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-06 | -$500.00K 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | -$700.00K 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $29.00M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | -$56.80M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |